Report Library
View More
HIV Treatment KOL Interview – Germa...
October 9, 2024
HIV Treatment KOL Interview – Ital...
October 9, 2024
HIV Treatment KOL Interview – US, M...
October 9, 2024
HIV Treatment KOL Interview – US, W...
October 9, 2024
Datamonitor Healthcare Oncology: Wa...
October 8, 2024
Datamonitor Healthcare I&I: Primary...
October 4, 2024
Datamonitor Healthcare Oncology: Ut...
October 4, 2024
Datamonitor Healthcare CV&Met: Duch...
October 4, 2024
Datamonitor Healthcare CV&Met: Atri...
October 3, 2024
Datamonitor Healthcare Respiratory:...
October 3, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 10/8/24 | Stealth Biotherapeutics | Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/8/24 | Merck (MRK) | Keytruda for Head and Neck Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/27/24 | Johnson (JNJ) | Darzalex Faspro for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/26/24 | AbbVie (ABBV) | Tavapadon for Parkinson's Disease (PD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/26/24 | Enanta (ENTA) | EDP-323 for Respiratory Syncytial Virus (RSV) Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 09/12/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/30/24 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 09/30/24 | Subscribers Only | Subscribers Only | Trial Announcement - Other |
| 09/30/24 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation (Emerging Markets) |
| 09/30/24 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |